Tolerating uncertainty: photodynamic therapy planning with optical property variation

Treatment planning is of utmost importance in interstitial photodynamic therapy, as it predicts the required light delivery to the target volume in an upcoming treatment. However, planning remains a major challenge due to several uncertainties such as the tissue optical properties and the concentrations of the photosensitizer and oxygen. Any difference in these parameters from the assumed values during planning could significantly affect the outcome of the actual treatment. This work introduces PDT-SPACE, a PDT light source power allocation using a convex optimization engine to minimize damage to organs-at-risk (OAR) with robustness against variation in tissue optical properties. Three power allocation methods are proposed and compared with respect to the resulting standard deviation in the damage to organs-at-risk and their runtime. The proposed approaches are demonstrated for ALA induced PpIX as photosensitizer in a virtual brain tumor that models a glioblastoma multiforme case. Results show that choosing a power allocation to minimize the OAR damage standard deviation under optical property variation tends to also minimize the tumor coverage as there is only one degree of freedom to optimize upon. This motivates simultaneous source position and power allocation optimization.

[1]  Stephen M. Moore,et al.  The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository , 2013, Journal of Digital Imaging.

[2]  B. Pogue,et al.  Tutorial on diffuse light transport. , 2008, Journal of biomedical optics.

[3]  Stephen A Boppart,et al.  Refractive index of carcinogen-induced rat mammary tumours , 2006, Physics in medicine and biology.

[4]  S. Jacques Optical properties of biological tissues: a review , 2013, Physics in medicine and biology.

[5]  Frédéric Pain,et al.  Optical properties of mice skull bone in the 455- to 705-nm range , 2017 .

[6]  Maximilien Vermandel,et al.  Photodynamic therapy for glioblastoma: A preliminary approach for practical application of light propagation models , 2018, Lasers in surgery and medicine.

[7]  Qiyin Fang,et al.  Dual-modality optical biopsy of glioblastomas multiforme with diffuse reflectance and fluorescence: ex vivo retrieval of optical properties , 2017, Journal of biomedical optics.

[8]  Stefan Andersson-Engels,et al.  Interstitial photodynamic therapy for primary prostate cancer incorporating real-time treatment dosimetry , 2007, SPIE BiOS.

[9]  P. Perriat,et al.  Multifunctional ultrasmall nanoplatforms for vascular-targeted interstitial photodynamic therapy of brain tumors guided by real-time MRI. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[10]  Qianqian Fang,et al.  Mesh-based Monte Carlo method using fast ray-tracing in Plücker coordinates , 2010, Biomedical optics express.

[11]  I. Yaroslavsky,et al.  Optical properties of selected native and coagulated human brain tissues in vitro in the visible and near infrared spectral range. , 2002, Physics in medicine and biology.

[12]  S. Gigan,et al.  Brain refractive index measured in vivo with high-NA defocus-corrected full-field OCT and consequences for two-photon microscopy. , 2011, Optics express.

[13]  Lothar Lilge,et al.  High-performance, robustly verified Monte Carlo simulation with FullMonte , 2018, Journal of biomedical optics.

[14]  Houra Mahmoudzadeh,et al.  A robust-CVaR optimization approach with application to breast cancer therapy , 2014, Eur. J. Oper. Res..

[15]  Evgueni Parilov,et al.  Interstitial Photodynamic Therapy—A Focused Review , 2017, Cancers.

[16]  K. Tománková,et al.  Photodynamic therapy for enhancing antitumour immunity. , 2012, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[17]  Stephen P. Boyd,et al.  Convex Optimization , 2004, Algorithms and Theory of Computation Handbook.

[18]  R. Rockafellar,et al.  Optimization of conditional value-at risk , 2000 .

[19]  V. M. Kiselev,et al.  Photophysical properties and in vitro photocytotoxicity of disodium salt 2.4-di(alpha-methoxyethyl)-deuteroporphyrin-IX (Dimegine). , 2019, Photodiagnosis and photodynamic therapy.

[20]  Timothy C Zhu,et al.  A review of in‐vivo optical properties of human tissues and its impact on PDT , 2011, Journal of biophotonics.

[21]  L. Lilge,et al.  Optimizing interstitial photodynamic therapy with custom cylindrical diffusers , 2018, Journal of biophotonics.

[22]  Ronald Sroka,et al.  Protoporphyrin IX Fluorescence and Photobleaching During Interstitial Photodynamic Therapy of Malignant Gliomas for Early Treatment Prognosis , 2013, Lasers in surgery and medicine.

[23]  Johannes Swartling,et al.  Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate. , 2007, Medical physics.

[24]  Lothar Lilge,et al.  Automatic interstitial photodynamic therapy planning via convex optimization. , 2018, Biomedical optics express.